DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: FLUVOXAMINE MALEATE
Summary for Tradename: FLUVOXAMINE MALEATE
|
| |||||||
Clinical Trials for: FLUVOXAMINE MALEATEFluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents Status: Terminated Condition: Obsessive Compulsive Disorder Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents Status: Completed Condition: Major Depressive Disorder Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine Status: Completed Condition: Schizophrenia Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor Status: Terminated Condition: Solid Tumors Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) Status: Not yet recruiting Condition: Obsessive Compulsive Disorder Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel Status: Completed Condition: Drug Interactions Between Clopidogrel and Serotonin Reuptake Inhibitors Impact of Omeprazole and Fluvoxamine on Platelet Response to Clopidogrel Status: Not yet recruiting Condition: Drug Interaction of Clopidogrel Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients Status: Recruiting Condition: SCHIZOPHRENIA 1 (Disorder) A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy Volunteers Status: Completed Condition: Healthy Volunteer Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood? Status: Completed Condition: Autism Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Exclusivity Expiration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr | FLUVOXAMINE MALEATE | fluvoxamine maleate | Tablet; Oral | 075897 | JAN 25, 2001 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Eon | FLUVOXAMINE MALEATE | fluvoxamine maleate | Tablet; Oral | 075888 | NOV 29, 2000 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Eon | FLUVOXAMINE MALEATE | fluvoxamine maleate | Tablet; Oral | 075888 | NOV 29, 2000 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genpharm | FLUVOXAMINE MALEATE | fluvoxamine maleate | Tablet; Oral | 075950 | OCT 15, 2001 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
